Tiziana Life Sciences attends 10th joint ACTRIMS-ECTRIMS meeting

TLSA•2026-10-21

Tiziana Life Sciences management will attend the meeting in Toronto from Oct. 21-23, 2026, to discuss its intranasal foralumab trial and potential collaboration and business development opportunities.

1. Meeting attendance

Tiziana Life Sciences management will attend the 10th joint ACTRIMS-ECTRIMS meeting in Toronto from Oct. 21-23, 2026. Representatives will discuss intranasal foralumab’s INFORM-MS trial in non-active secondary progressive multiple sclerosis, along with collaboration and business development opportunities.

Tiziana Life Sciences attends 10th joint ACTRIMS-ECTRIMS meeting

1. Meeting attendance

Related News

Einride expands NVIDIA collaboration to evaluate AI model for autonomous trucks

Building the ultimate game night: Domino's and Minecraft Dungeons II team up for a block-shaped collaboration

Deutsche Telekom, Nokia and NVIDIA achieve 10-15% uplink throughput gains in AI-RAN lab tests

NextEra Energy announces availability of third-quarter 2026 financial results release

Deutsche Bank raises E.L.F. Beauty target price to $105 from $78